Literature DB >> 18396782

Successful rescue of an apocrine gland carcinoma metastatic to the cervical lymph nodes by mitoxantrone coupled with trains of permeabilizing electrical pulses (electrochemotherapy).

Enrico P Spugnini1, Ivan Dotsinsky, Nikolay Mudrov, Angelo De Luca, Carlo Codini, Gennaro Citro, Alfredo D'Avino, Alfonso Baldi.   

Abstract

Canine apocrine gland carcinoma is a locally aggressive neoplasm that can occasionally lead to metastatic spread, thus mimicking the behavior of their human counterpart. In this paper we describe the successful treatment of a cervical metastatic spread of this neoplasia by using mitoxantrone selectively driven within the tumor cells by trains of biphasic pulses. The dog experienced tumor reduction from the first cycle of electrochemotherapy (ECT) and complete remission by the time of its fourth session. Neither systemic or local toxicities were detected during the whole course of therapy. The dog is in complete remission after six months from his last treatment. Electrochemotherapy is a safe and efficacious therapy for metastatic carcinoma and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396782

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.

Authors:  Jeffry Cutrera; Glenn King; Pamela Jones; Kristin Kicenuik; Elias Gumpel; Xueqing Xia; Shulin Li
Journal:  J Cell Mol Med       Date:  2015-01-27       Impact factor: 5.310

Review 2.  Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.

Authors:  Enrico P Spugnini; Gennaro Citro; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-08-14

3.  Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.

Authors:  Enrico P Spugnini; Ivan Dotsinsky; Nikolay Mudrov; Gennaro Citro; Alfredo D'Avino; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.